In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Cardinal Health's current price implies a 31% undervaluation relative to a $296.95 fair value with high confidence across multiple methods. Financial health reveals strong leverage but weak profitability and growth, increasing fundamental risk. Monte Carlo outcomes show high volatility and downside risk near 31%, reflecting significant uncertainty in valuation.